机构：[1]Department of Dermatology, Peking University First Hospital, Beijing, China.[2]National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.[3]NResearch Center for Medical Mycology, Peking University, Beijing, China.[4]Department of Dermatology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.临床科室皮肤性病科首都医科大学附属北京同仁医院首都医科大学附属同仁医院
This research was supported by National High Level Hospital Clinical Research Funding (‘Star of Outlook’ Scientific Research Project of Peking University First Hospital).
第一作者机构：[1]Department of Dermatology, Peking University First Hospital, Beijing, China.[2]National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.[3]NResearch Center for Medical Mycology, Peking University, Beijing, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Dermatology, Peking University First Hospital, Beijing, China.[2]National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.[3]NResearch Center for Medical Mycology, Peking University, Beijing, China.
推荐引用方式(GB/T 7714)：
Li Tingting,Tao Rong,Yang Li,et al.Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis[J].The British Journal Of Dermatology.2025,doi:10.1093/bjd/ljaf095.
APA：
Li Tingting,Tao Rong,Yang Li,Wan Zhe,Li Ruoyu&Wang Ruojun.(2025).Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis.The British Journal Of Dermatology,,
MLA：
Li Tingting,et al."Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis".The British Journal Of Dermatology .(2025)
医学